Jan Bubeník - Concepedia

Author

Jan Bubeník

Czech Academy of Sciences, Institute of Molecular Genetics

Also Known As

Bubenik, J, J BUBENIK, J Bubenik, J Bubeník, J. Bubenik, J. Bubeník, Jan Bubenik, Jan Bubeník

360

Publications

326

Citations

H-Index

Concepts

All Affiliations

Czech Academy of Sciences, Institute of Molecular Genetics Czech Academy of Sciences Brno University of Technology

About

Jan Bubeník is an author at Czech Academy of Sciences, Institute of Molecular Genetics specializing in medicine, immunology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	52
2	Engineering	3	3	59
3	Health Sciences	1	1	11
4	Public Health	1	1	18
5	Chemical Engineering	1	1	16

Jan Bubeník

Publications

139

Citations

H-Index

Page 1

	Year	Citations
Behavior and properties of ultra-lightweight concrete with foamed glass aggregate and cellulose fibres under high temperature loading Jan Bubeník, Jiří Zach, Klára Křížová, Journal of Building Engineering Materials ScienceFoamed Glass AggregateFiber ReinforcementEngineeringCivil Engineering	2023	22
The use of foam glass based aggregates for the production of ultra-lightweight porous concrete for the production of noise barrier wall panels Jan Bubeník, Jiří Zach Transportation research procedia Foam GlassEngineeringNoise ControlCement-based Construction MaterialCivil Engineering	2019	21
Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I‐deficient and ‐proficient HPV16‐associated tumours Milan Reiniš, Jana Šímová, Jan Bubeník International Journal of Cancer	2005	18
Animal models for development of therapeutic HPV16 vaccines (Review) Jan Bubeník International Journal of Oncology ImmunologyPathologyHpv Type 16Tumor BiologyViral Oncology	2002	18
Development of Vacuum Insulation Panels with Utilization of Organic By-Products Jiří Zach, Vítězslav Novák, Jitka Peterková, Energies EngineeringEnergy-saving MaterialEnergy EfficiencyEnergy ConversionGreen Building	2020	16
Monoclonal antibodies against human urinary bladder carcinomas: Selectivity and utilization for gamma scintigraphy Jan Bubeník, J. Kieler, Peter Perlmann, European Journal of Cancer and Clinical Oncology Urological ResearchUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	1985	13
Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment Jan Bubeník, Jana Šímová, D Bubeníková, Journal of Cancer Research and Clinical Oncology Cyclophosphamide PretreatmentHematological MalignancyAutoimmune DiseaseMedicineMalignant Blood Disorder	1995	11
Therapy for minimal residual tumor disease: β‐Galactosylceramide inhibits the growth of recurrent HPV16‐associated neoplasms after surgery and chemotherapy Jana Šímová, M Indrová, Jana Bieblová, International Journal of Cancer Surgical OncologyImmunologyPathologyNatural Killer TImmunotherapy	2009	10
The Use of Advanced Environmentally Friendly Systems in the Insulation and Reconstruction of Buildings Jiří Zach, Vítězslav Novák, Jitka Peterková, Buildings	2023	10

Page 1